11.17.11 cen healthcare chris schaffer presentation
TRANSCRIPT
http://www.bme.cornell.edu/schafferlab
Your brain on Alzheimer's disease: the potential role of slowed blood flow
Chris B. Schaffer
Alzheimer’s disease is the leading cause of dementia in the elderly
Auguste D., first Alzheimer’s patient described by Alois Alzheimer
Alzheimer’s is caused by neuronal loss due to neurotoxic effects of aggregated A-beta peptide
K. Blennow, et al., Lancet (2006)
Alzheimer’s pathology molecular mechanisms
K. Blennow, et al., Lancet (2006)
Alzheimer’s pathology molecular mechanisms
Alzheimer’s is caused by neuronal loss due to neurotoxic effects of aggregated A-beta peptide
A-beta is produced by neurons andcleared through the vasculaturecleared through the vasculature
Blood flow deficits to the brain also observed in Alzheimer’s patients
Blood flow deficits to the brain also observed in Alzheimer’s patients
• 20-30% decreased brain blood flow compared to non Alzheimer controls
• This blood flow decrease could be cognitively important, but the origin remains unclear
We used advanced imaging techniques to study disruptions in microvascular blood flow in mice that are engineered to get
Alzheimer’s disease
Two-photon excitation of fluorescent dyes leads to emission that originates only from the focal volume
Z. Huang, et al., belfield.cos.ucf.edu/one vs two-photon excitation.html
Image is formed by scanning laser focus through the sample and recording fluorescence intensity
Image is formed by scanning laser focus through the sample and recording fluorescence intensity
Image fluorescently-labeled features in brain of anesthetized rodent with glass-covered craniotomy
QuickTime and aªMPEG-4 Video decompressor
are needed to see this picture.
Imaging fluorescent blood plasma yields a 3-D cortical “micro-angiography”
In vivo imaging of vasculature and amyloid plaques in AD mouse modelsamyloid plaques in AD mouse models
plaques labeled by methoxy-X04vasculature with intravenous dye injection
Aged APPswe/PS1 mice with craniotomies
Dye labels blood plasma, but not blood cells, allowing identification of flowing vs. stalled vessels
QuickTime and aª decompressor
are needed to see this picture.
Fraction of capillaries with stalled blood flow increased to ~2% in mouse models of AD
Temporary stalls that shift between capillary segments, rather than permanent occlusions
2843 capillaries in 6 AD mice2475 capillaries in 4 WT mice
Labeling to distinguish red blood cells, leukocytes, and thrombi as potential cause of stalls
leukocytes: rhodamine-6G and Hoechst
thrombi: rhodamine-6G
red blood cells: unlabeled
In vivo imaging of capillary stalls with rhodamine-6G and Hoechst labeling
red - Texas-Red dextrangreen - rhodamine 6Gblue - methoxy-X04 and Hoescht
Majority of capillary stalls in AD mouse models are caused by leukocyte plugs
How does a single stalled capillary affect blood flow?affect blood flow?
mm/s
N. Nishimura, et al., Nature Methods 3, 99 (2006)
Laser injury to vessel triggers clotting
Map changes in flow after capillary clot
baseline flow post-clot flow
A single stalled capillary causes reduced blood flow in multiple downstream vessel branches
N. Nishimura, et al., Nature Methods 3, 99 (2006)
Pos
t-cl
ot b
loo
d flo
w s
pee
d(f
ract
ion
of b
ase
line)
Map of blood vessels and amyloidplaques from AD mouseplaques from AD mouse
Location of stalled capillaries
Simulate blood flow changes in capillaries downstream from plugged vessels
Simulate blood flow changes in capillaries downstream from plugged vessels
Simulate blood flow changes in capillaries downstream from plugged vessels
Increases in number of stalled capillaries causes decreases in average cerebral blood flow
2% of capillaries stalled predicts a 30% decrease in flow compared to controls
Leukocyte plugging of capillary segments could explain blood flow deficits observed in AD
• In humans, blood flow reduced by 20-30% compared to non-AD age-matched controls [1]
• In mouse models of AD, flow reduced by ~30% compared to wild-type animals [2]
1. Farkas E, Luiten PG. (2001) Cerebral microvascular pathology in aging and Alzheimer's disease. Prog Neurobiol 64:575-611
2. Niwa K, Kazama K, Younkin SG, Carlson GA, Iadecola C. (2002) Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein. Neurobiol Dis 9:61-68
Summary
• 2% of capillaries are stalled in AD mouse models
• Stalls are caused by leukocytes plugging capillary segments
• This rate of capillary stalling could produce ~30% decrease in cerebral blood flow, consistent with observations in humans and mouse models
• Suggests that Aβ aggregates cause vascular inflammation that leads to firm adhesion of leukocytes to the endothelium
• Provides a novel potential target for treatment of blood flow deficits in AD, which could improve cognitive function
Cyclic relationship between vascular stalls and Aβ aggregates as a driver of AD progression
leukocyteplugs
Aβ aggregates
Collaborators
• Cornell
• Dr. Nozomi Nishimura
• Calvin Kersbergen
• Gabriel Otte
• Joan Zhou
• Jeff Beverly
• Elizabeth Slack
• Weill Cornell Medical College
• Prof. Costantino Iadecola
Thanks to William Klunk for donation of methoxy-X04
Acknowledgements
To occlude a small blood vessel, we optically injure the vessel to initiate endogenous clotting cascade
N. Nishimura, et al., Nature Methods 3, 99 (2006)
Femtosecond laser irradiation to produce a clot in a targeted, sub-surface brain capillary
QuickTimeª and aMotion JPEG OpenDML decompressor
are needed to see this picture.